ARCHIVES

Selumetinib Displays Positive Results, 60% with Stable Disease

This article is from The Cancer Letter archive.

Vol. 34 No. 4 | April 29, 2011

Download PDF Visit The Full Archive

Related Articles

MSKCC In Outreach Agreement With Phelps

December 1, 1995

Major Changes In NCI Drug screening Tumor Panels Approved

June 18, 1982

Drug Company Cries Foul Over Clams Of Taxotere’s Superiority To Taxol

June 11, 1993

NCI Programs: Institute To Develop Plans For Large Trial Of Spiral CT Scanning For Lung Cancer

November 5, 1999

Yarbro-Chabner Debate Continues

April 29, 1983

Long-Term Effect Of One Phase III Trial: Benefit For Thousands Of Patients

November 27, 2009